BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 169 filers reported holding BLUEBIRD BIO INC in Q2 2023. The put-call ratio across all filers is 2.66 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 7,382,827 | $24,289,501 | 3.58% |
| PFM Health Sciences, LP | 7,285,121 | $23,968,048 | 0.93% |
| Endurant Capital Management LP | 281,441 | $925,941 | 0.81% |
| Lion Point Capital, LP | 531,256 | $1,747,832 | 0.79% |
| Birchview Capital, LP | 249,200 | $819,868 | 0.62% |
| Granahan Investment Management | 4,856,322 | $15,977,299 | 0.49% |
| Frazier Life Sciences Management, L.P. | 1,709,907 | $5,625,594 | 0.34% |
| Ikarian Capital, LLC | 412,628 | $1,357,545 | 0.22% |
| Summit X, LLC | 222,445 | $731,870 | 0.18% |
| Virtus ETF Advisers LLC | 89,022 | $292,882 | 0.17% |
| PROFUND ADVISORS LLC | 294,681 | $969,500 | 0.05% |
| Baker Brothers Advisors | 2,499,715 | $8,224,062 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,090,910 | $6,879,094 | 0.04% |
| Ghisallo Capital Management LLC | 100,000 | $329,000 | 0.04% |
| Rafferty Asset Management, LLC | 1,837,462 | $6,045,250 | 0.03% |
| Woodline Partners LP | 782,892 | $2,575,715 | 0.03% |
| Jump Financial, LLC | 222,260 | $731,235 | 0.03% |
| CAXTON ASSOCIATES LP | 52,925 | $174,123 | 0.03% |
| HOLDERNESS INVESTMENTS CO | 20,649 | $67,935 | 0.02% |
| CHANNEL WEALTH LLC | 12,500 | $41,125 | 0.02% |
External links
This page lists BLUEBIRD BIO INC's shareholders in Q2 2023. To view BLUEBIRD BIO INC's shareholder history, click here.